Stock comparison
METTLER TOLEDO INTERNATIONAL INC/ is 5.0x more valuable than 10x Genomics, Inc. by market capitalization ($27.51 B vs $5.50 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MTD is larger
METTLER TOLEDO INTERNATIONAL INC/ is 5.0x more valuable than 10x Genomics, Inc. by market capitalization ($27.51 B vs $5.50 B).
Market value leader
MTD
METTLER TOLEDO INTERNATIONAL INC/ is 5.0x more valuable than 10x Genomics, Inc. by market capitalization ($27.51 B vs $5.50 B).
Revenue leader
MTD
TXG: $642.82M vs MTD: $4.03B.
Profit leader
MTD
TXG: -$43.50M vs MTD: $869.19M.
Margin leader
MTD
TXG: -6.8% vs MTD: 21.6% net margin.
| Metric | TXG | MTD |
|---|---|---|
| Market cap | $5.50 B | $27.51 B |
| US-listed rank | #1345 | #505 |
| Revenue (latest FY) | $642.82M | $4.03B |
| Net income (latest FY) | -$43.50M | $869.19M |
| Net margin | -6.8% | 21.6% |
| P/E (trailing FY) | - | 31.6x |
| SEC filings | 652 | 1,692 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
METTLER TOLEDO INTERNATIONAL INC/ is 5.0x more valuable than 10x Genomics, Inc. by market capitalization ($27.51 B vs $5.50 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while METTLER TOLEDO INTERNATIONAL INC/ reported $4.03B.
Full pages: 10x Genomics, Inc. and METTLER TOLEDO INTERNATIONAL INC/, or browse the full rankings.